secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001116463-24-000051
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure acquires Sherlock Biosciences; deal terms not disclosed in 8-K filing
-----------------------------------------------------------------------------

- OraSure announced acquisition of Sherlock Biosciences on December 19, 2024, but no deal value or financial terms provided.
- The 8-K furnishes an investor presentation (Exhibit 99.1) with only a title slide; no new substantive details were given.
- Acquisition press release referenced as Exhibit 99.2 but full text not included in the filing excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000111646324000051/0001116463-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000111646324000051/osur-20241219.htm
  HTML page:      https://secwatch.observer/filing/0001116463-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer